🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and assertions of rapid UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.

Some professionals stated the popularity for retatrutide could be linked to the rising price of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be marketed or supplied for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.

Service Response and Content Removal

According to the social media company, the service has removed problematic content and prohibited associated keywords and search suggestions. The organization stated it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Research also discovered groups with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at home.

Within moments of entering one group, a vendor shared contact information, where most purchases take place. The vendor provided an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Inside these groups, messages display black plastic parcels with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how long a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for the messaging service said it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they cannot confirm. Although the science behind this drug is sound, these online products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has already seen patients harmed by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to possibly significant health risks”.